Low prevalence of Gram-positive isolates showing elevated lefamulin MIC results during the SENTRY surveillance program for 2015–2016 and characterization of resistance mechanisms

Abstract

This study investigated the molecular mechanisms possibly associated with non-wild-type MICs for lefamulin among staphylococci and streptococci included in the lefamulin surveillance program from 2015 to 2016. A total of 2,919 Staphylococcus aureus, 276 coagulase-negative staphylococci (CoNS), 3,923 Streptococcus pneumoniae, 389 -hemolytic, and 178 viridans group streptococci isolates were included in the surveillance studies. Eleven (0.3% of all S. aureus) S. aureus isolates with lefamulin MICs above the staphylococcal epidemiological cutoff (ECOFF) value (0.25 g/ml) were selected for this study. Eight (72.7%) S. aureus (lefamulin MIC, 0.5 to 4 g/ml) isolates carried vga(A or E), one isolate (MIC, 32 g/ml) carried lsa(E), one isolate (MIC, 16 g/ml) had an alteration in L4, and one strain (MIC, 0.5 g/ml) did not carry any of the investigated resistance mechanisms. A total of 14 (5.1% of all CoNS) CoNS isolates had lefamulin MICs (0.5 to 32 g/ml) above the ECOFF. Similar to S. aureus, 8 (57.1%) CoNS (lefamulin MIC, 1 to 8 g/ml) isolates carried vga(A or B), while 2 isolates (MIC, 4 to 32 g/ml) carried cfr. High genetic diversity was observed among staphylococci, although 3 S. aureus isolates belonged to sequence type 398 (ST398). Among the 3 Streptococcus agalactiae and 3 viridans group streptococci (0.1% of all streptococci surveyed) isolates selected for additional characterization, all but 1 isolate carried lsa(E). This study documents a low occurrence of surveillance isolates exhibiting a non-wild-type MIC for lefamulin, and among these isolates, vga and lsa(E) prevailed in staphylococci and streptococci, respectively.